SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-041536
Filing Date
2018-08-02
Accepted
2018-08-02 08:01:32
Documents
39
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv499288_10q.htm 10-Q 460907
2 EXHIBIT 10.2 tv499288_ex10-2.htm EX-10.2 9177
3 EXHIBIT 31.1 tv499288_ex31-1.htm EX-31.1 8338
4 EXHIBIT 31.2 tv499288_ex31-2.htm EX-31.2 8405
5 EXHIBIT 32.1 tv499288_ex32-1.htm EX-32.1 3529
  Complete submission text file 0001144204-18-041536.txt   4690743

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT gnmx-20180630.xml EX-101.INS 1651797
7 XBRL TAXONOMY EXTENSION SCHEMA gnmx-20180630.xsd EX-101.SCH 33034
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gnmx-20180630_cal.xml EX-101.CAL 16454
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gnmx-20180630_def.xml EX-101.DEF 152883
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE gnmx-20180630_lab.xml EX-101.LAB 184050
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gnmx-20180630_pre.xml EX-101.PRE 167584
Mailing Address 435 DEVON PARK DRIVE, SUITE 715 WAYNE PA 19087
Business Address 435 DEVON PARK DRIVE, SUITE 715 WAYNE PA 19087 610-254-4201
Aevi Genomic Medicine, Inc. (Filer) CIK: 0001138776 (see all company filings)

IRS No.: 980217544 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35112 | Film No.: 18986728
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1